Cohance Lifesciences, India Cements and Blue Jet Healthcare Lead Top Gainers; MRPL, SPL Petro and Shriram Finance Among Top Losers

These gains followed a sharp fall in both the indices of 2.7% for the past three days, driven by escalating crude oil prices due to geopolitical concerns. Brent crude oil was seen trading around $107 per barrel, and the U.S.-Iran negotiations were not going well, which kept investors wary.

Against this scenario, several stocks within the Nifty 500 index showed significant price movement along with volume changes to emerge as leaders and laggards of the day.

Top Gainers

One of the notable gains was witnessed in Cohance Lifesciences, which closed the day on a high note by achieving a 20% upper circuit on Monday. The firm is a technology-enabled CDMO platform that offers expertise in complex chemistry, ADCs, oligos, and novel APIs. This gain was fueled by heightened investor interest in the stock, with trading volumes reaching 1.36 crore against the 30-day average trading volume of 37.32 lakh shares.

The reason behind the spike in investor interest was a key personnel move announced recently. Cohance Lifesciences announced that Umang Vohra will take up the role of Executive Chairman and Group CEO from July 1. This appointment marks the start of a new era for the firm as it undergoes a period of transformation. Umang Vohra, who holds rich experience in the industry, was previously the CEO of Cipla.

Also in focus were shares of India Cements that surged by 12% to mark two months highs post its Q4FY26 numbers. The cement manufacturer and member of the UltraTech Cement conglomerate registered a massive growth of 4X in net profit at ₹60 crore against ₹15 crore last year. Revenues expanded by 3% to ₹1,218 crore. Meanwhile, there was a sharp increase in EBITDA to ₹179 crore from ₹23 crore.

Operating performance indicators saw an improvement as well with an increase in capacity utilization from 73% to 84%. EBITDA per tonne went up to ₹497 as against ₹305 in the last quarter. Shares of the company also witnessed their biggest trading volume since December 2024, touching levels of 1.48 crore shares as against its 30-day average volume of 6.85 lakh shares.

Finally, Blue Jet Healthcare came in the limelight after registering its 10% upper circuit. The specialty chemical and pharmaceutical intermediary manufacturer for foreign pharma companies experienced a sharp surge in volumes. The volumes shot up to close to double its 30-day average of 6 lakh shares. This move is believed to have been supported on the back of sectoral strength in pharma and healthcare stocks.

Top Losers

For the losers, MRPL (Mangalore Refinery and Petrochemicals Limited), operating in the petroleum refining and petrochemical industry, slipped 7.15% to close at ₹173.05. The slide seems to have been fueled by profit-taking following its recent rise, while refinery margins continue to face pressure, which is an important contributor to the company’s earnings. This is a very cyclical stock, and changes tend to correlate with changes in crude prices and margins.

SPL Petrochemicals, a producer of polystyrene and petrochemicals, dropped 4.34% to end at ₹776.75. No news could be found related to any specific company development that might have caused the move; thus, the drop looks like it was triggered by external factors, perhaps due to weakness in the petrochemical sector as well as crude price volatility.

Shriram Finance, one of India's premier NBFCs that concentrates on consumer loans and automobile finance, fell by 4.08% to ₹970 despite its excellent Q4FY26 performance. The NBFC registered a 41% YoY increase in its bottom line along with growth in the asset management portfolio. Nevertheless, the stock faced selling activity, possibly attributed to profit-taking amid previous gains and lukewarm market response, considering that the good quarterly numbers were already anticipated. Despite the price fall, analysts continue to hold a favorable view towards the stock.

Conclusion

It was evident from Monday’s trading that there had been a change in the market sentiment as there was a strong buying activity in the pharmaceuticals, cement, and midcap sectors due to volume support and triggers such as good results and changes in leadership. On the other hand, the fall of stocks such as MRPL and Shriram Finance is an indication of the significance of profit-taking despite good fundamentals.

In general, the market continues to be influenced by external factors such as crude prices, geopolitics, and stock-specific triggers.